Renal fibrosis: research progress on mechanisms and therapeutic strategies

Cheng-Xiao Yin1, Jia-Rui Fan1, Xiao-Gang Du1

  • 1Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

PubMed

Insights

Renal fibrosis (RF) involves complex mechanisms like signaling pathways and aging. Targeting these pathways offers new therapeutic strategies for chronic kidney disease treatment.

Area of Science:

  • Nephrology
  • Pathology
  • Molecular Biology

Background:

  • Renal fibrosis (RF) is a common pathway in chronic kidney diseases, leading to end-stage renal disease.
  • Multiple mechanisms contribute to RF, including aberrant signaling pathways, microRNAs, aging, and autophagy dysfunction.
  • Understanding these mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To explore recent advancements in understanding the mechanisms of renal fibrosis.
  • To review novel therapeutic approaches targeting the identified mechanisms of RF.
  • To provide a comprehensive overview of RF pathogenesis and treatment strategies.

Main Methods:

  • Literature review of recent studies on renal fibrosis mechanisms.
  • Analysis of research on therapeutic interventions targeting signaling pathways, microRNAs, aging, and autophagy.
  • Synthesis of information on fibrotic ecological niches and their role in RF.

Main Results:

  • Identified key molecular and cellular mechanisms driving renal fibrosis.
  • Highlighted the potential of targeting specific pathways (e.g., signaling, microRNAs) for RF treatment.
  • Discussed the role of aging and autophagy disorders in fibrotic processes.

Conclusions:

  • Targeting the diverse mechanisms of renal fibrosis presents promising therapeutic avenues.
  • Further research into inhibiting or delaying RF development is essential for clinical application.
  • Comprehensive understanding of RF pathogenesis is key to novel treatment development.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K